11 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
CRP DIAGNOSTIC ASSAY
FDA 510(k)
FDA Class 2
·Immunology
Neo-Tee T-Piece Resuscitator
FDA UDI
MERCURY ENTERPRISES, INC.·10641043508367·
GLENOID, HEAD W/RETAINING SCREW, RSP, 36MM, NEUTRAL
FDA Adverse Event
Injury
·ENCORE MEDICAL L.P·Product code PHX·December 29, 2023
BIOSORBPDX BIOABSORBABLE FIXATION SYSTEM
FDA 510(k)
FDA Class 2
·Dental
AT WORK DRUG TEST, MODEL 9147T AWT
FDA 510(k)
FDA Class 2
·Clinical Toxicology
FLUENCY PLUS TRACHEOBRONCHIAL STENT GRAFTS
FDA Adverse Event
Malfunction
·ANGIOMED GMBH & CO. MEDIZINTECHNIK·Product code JCT·May 22, 2009
BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES
FDA Adverse Event
Malfunction
·BECTON, DICKINSON AND COMPANY (BD)·Product code JKA·July 10, 2019
UNKNOWN DEPUY 58MM GRIPTION SOCKET
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS, INC. 1818910·Product code JDI·April 10, 2013
RIATA PASSIVE FIXATION
FDA Adverse Event
Injury
·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code LWS·May 27, 2008
LOCKING SCREWS, CROSS-PIN, DIAM.2.0X8MM, (5/PACKAG
FDA Adverse Event
Injury
·STRYKER OSTEOSYNTHESIS FREIBURG·Product code JEY·April 1, 2011
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014